期刊文献+

初诊急性髓系白血病患者十种常见突变基因的突变组分析 被引量:9

Mutaome analysis including 10 common mutated genes in newly diagnosed acute myeloid leukemia patients
原文传递
导出
摘要 目的 探讨初诊急性髓系白血病(AML)患者中最常见的10种突变基因的突变组合规律.方法 选取AML患者129例,基因测序法检测初诊时骨髓样本中ASXL1、CEBPA、DNMT3A、FLT3、IDH1/2、KIT、NPM1、PHF6和TET2基因突变.结果 68.99%(89/129)患者上述基因突变阳性,30.23%(39/129)同时有多种基因突变.激酶类基因FLT3和KIT突变互斥,不同时出现.FLT多与其他基因伴随突变,而KIT突变多单独出现.转录因子基因CEBPA、NPM1和PHF6可相互伴随突变.表观遗传调控基因ASXL1、DNMT3A、IDH1/2和TET2的突变多与上述两组基因突变同时出现,但该组基因之间较少伴随突变.结论 首次对初诊AML中的突变组按基因的功能和分类进行谱型分析,显示基因突变的组合具有一定的规律,与基因的功能和分类相关. Objective To investigate the mutaome profile of the 10 common mutated genes in newly diagnosed acute myeloid leukemia (AML) patients.Methods Gene mutations of ASXL1,CEBPA,DNMT3A,FLT3,IDH1/2,KIT,NPM1,PHF6 and TET2 were analyzed using Sanger sequencing method in bone marrow samples of 129 newly diagnosed AML patients.Results 68.99 % (89/129) patients carried at least one mutation,and 30.23 % (39/129) carried multiple mutations.Mutations of kinase gene FLT3 and KIT were mutually exclusive,and FLT3 mutations occured more often with other mutations,while KIT mutations usually occured alone.Mutations of transcription factor genes CEBPA,NPM1 and PHF6 were accompany with each other.Mutations of epigenetic regulation genes ASXL1,DNMT3A,IDH1/2 and TET2 were mutually exclusive,but were accompany with mutations of kinase or transcription factor genes.Conclusions There are certain rules in the appearance of genetic mutations,and which are related to the function and classification of genes.
出处 《白血病.淋巴瘤》 CAS 2015年第3期161-164,共4页 Journal of Leukemia & Lymphoma
基金 国家自然科学基金青年科学基金(81102211)
关键词 白血病 髓样 急性 初诊 基因突变 突变组 Leukemia,myeloid,acute Newly diagnosed Gene mutation Mutaome
  • 相关文献

参考文献22

  • 1刘红星.肿瘤突变组研究进展和靶向鸡尾酒疗法的美好前景[J].中国处方药,2013,11(4):38-41. 被引量:7
  • 2Khasawneh MK, AbdeI-Wahat O. Recent discoveries in mole 'uhu" characterization f acute myeloid leukemia [ J ]. Curr |temalol Malig Rap, 2014, 9(2): 93-99.
  • 3王芳,张阳,陈雪,刘红星.白血病基因突变研究和应用进展:第56届美国血液学会年会报道[J].白血病.淋巴瘤,2015,24(3):157-160. 被引量:4
  • 4Naoe T, Kiyoi H. Genc mutations of acute myeloid leukemia in the genorne era [ J ]. In/J Hematol, 2013,97 ( 2 ) : 165-174.
  • 5沈杨,陈赛娟.急性白血病基因突变与多步骤发病机制和临床相关性[J].中国科学:生命科学,2013,43(1):39-45. 被引量:12
  • 6Huang Y, Rao A. Connections between TET proteins and aberrant DNA modification in cancer [ J ]. Trends Genet, 2014, 30 ( 10 ) : 464-474.
  • 7Krauth MT, Alpermann T, Baeher U, et al. WTI mutations are secondary events in AML, show varying frequencies and impact on prognosis between genetic subgroups [ J ]. Lenkemia, 2015, 29 ( 3 ) : 660-667.
  • 8Welch JS, Ley TJ, Link DC, et al. The origin and evolution of mutations in acute myeloid leukemia [ J ]. Cell, 2012, 150 ( 2 ) : 264-278.
  • 9Hanahan D, Weinberg IRA. Halhnarks of cancer: the next generalion [J ]. Cell, 2011, 144(5 ) ; 646-674.
  • 10Tomasetti C, Vogelstein B. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stein cell divisions [ J ]. Science, 2015, 347 ( 6217 ) : 78-81.

二级参考文献105

  • 1Nowell PC, Hungerford DA. Chromosomestudies on normal and leukemic human leukocytes. J Natl Cancer Inst,1960,25:85-109.
  • 2Shtivelman E, Lifshitz B, Gale RP, et al. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell,1986,47(2):277-284.
  • 3Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol,2008,26(10):1135-1145.
  • 4Hanahan D, Weinberg RA. The hallmarks of cancer. Cell,2000,100(1):57-70.
  • 5Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell,2011,144(5):646-674.
  • 6Grossmann V, Schnittger S, Kohlmann A, et al. A novel hierarchical prognostic model of AML solely based on molecular mutations. Blood,2012,120(15):2963- 2972.
  • 7Stratton M R, Campbell PJ, Futreal PA. The cancer genome. Nature,2009,458(7239):719-724.
  • 8Walter M J, Shen D, Ding L, et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med,2012,366(12):1090-1098.
  • 9Liu H, Zhu P, Tong C, et al. Clonal evolution of BCR-ABL1 kinase domain mutation in tyrosine kinase inhibitor treatment patient. Blood,2010,116(21):597.
  • 10Patel JR Gonen M, Figueroa ME, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med,2012,366(12):1079- 1089.

共引文献19

同被引文献98

  • 1王莉红,周春林,张新伟,陈森,王敏,王建祥.FLT3基因内部串联重复突变与急性白血病的关系及临床意义[J].中华血液学杂志,2004,25(7):393-396. 被引量:35
  • 2王小钦,林果为.282例原发性骨髓增生异常综合征诊断和分型的前瞻性临床研究[J].中华血液学杂志,2006,27(8):546-549. 被引量:34
  • 3李娟.继发性单克隆免疫球蛋白血症的诊断与治疗[J].中国实用内科杂志,2007,27(19):1497-1499. 被引量:3
  • 4Bolli N, Manes N, Mckerrell T, et al. Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol [ J ]. Haematologica, 2015, 100 ( 2 ) : 214-222.
  • 5Mullighan CG. Genome sequencing of lymphoid malignancies [ J ]. Blood, 2013, 122( 24 ) : 3899-3907.
  • 6Yan X J, Xu J, Gu Z H, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia [ J ]. Nat Genet, 2011,43 ( 4 ) : 309-315.
  • 7Walter MS, Shen D, Ding L, et al. Clonal architecture of secondary acut myeloid leukemia [ J ]. N Eng[ J Med, 2012, 366 ( 12 ) : 1090-1098.
  • 8Patel JP, Gonen M, Figneroa ME, et al. Prognostic relevance of integrated genetic pr iling in acute myeloid leukemia [ J ]. N Engl J Med, 2012, 366( 12 ) : 107941089.
  • 9Nangalia J, Massie CE, Baxter E J, et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2 [ J ]. N Engt J Med, 2013, 369 ( 25 ) : 2391-2405.
  • 10Hobbs GS, Rampal RK. Clinical and molecular genetic characterization of myelofibmsis [ J ]. Curr Opin Hematol, 2015, 22 ( 2 ) : 177-183.

引证文献9

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部